IL13 and Alzheimer disease: To induce an AD phenotype, HSEs were treated with a TH2-associated cytokine mix (20 ng/ml IL-4, 10 ng/ml IL-5 and 10 ng/ml IL-13), as AD is mainly a TH2-driven disease (Fiset et al., 2006).